WellAir provides HVAC air purification solutions using bipolar ionization and NanoStrike technology to reduce indoor air pollutants, including viruses, bacteria, and volatile organic compounds. Their products ensure cleaner and safer indoor environments, addressing the health risks associated with poor indoor air quality.
Funding
$8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Indoor air often contains a high concentration of pollutants, including viruses, bacteria, volatile organic compounds (VOCs), fungal spores, and allergens, which can negatively impact health. Traditional HVAC systems may not effectively address these pollutants, leading to health risks, especially since individuals spend a significant amount of time indoors.
Solution
WellAir provides air purification and disinfection solutions designed to improve indoor air quality using technologies like bipolar ionization and NanoStrike. Their products are designed for whole-building HVAC systems and portable units, reducing airborne pathogens and pollutants. WellAir's solutions aim to create cleaner and safer indoor environments in commercial, residential, healthcare, and educational settings by inactivating viruses, bacteria, mold spores, VOCs, and particulate matter. The company's products are validated to UL 2998 for zero ozone emissions and UL 867 safety certified.
Target Audience
WellAir's target audience includes commercial building owners, residential homeowners, healthcare facilities, educational institutions, and other organizations seeking to improve indoor air quality and reduce the risk of airborne infections.
Features
- Whole-building HVAC air purification using bipolar ionization to reduce particulate matter, odors, VOCs, viruses, and bacteria.
- Residential HVAC air purification solutions for single and multi-family homes.
- Portable, medical-grade air disinfection devices using NanoStrike technology to inactivate airborne pathogens and pollutants.
- Validated to UL 2998 for zero ozone emissions and UL 867 safety certified.
- Solutions for commercial offices, education environments, medical facilities, hotels, and dental suites.
- Reduction of viruses such as SARS-CoV-2, Influenza, and Norovirus.
- Reduction of bacteria such as E. coli, MRSA, and Tuberculosis.
- Reduction of particulate matter, including PM1.0 and PM2.5.